123 results on '"Brorson, Kurt A."'
Search Results
2. High Performance Size Exclusion Chromatography and High-Throughput Dynamic Light Scattering as Orthogonal Methods to Screen for Aggregation and Stability of Monoclonal Antibody Drug Products
3. The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing
4. An ICP-MS platform for metal content assessment of cell culture media and evaluation of spikes in metal concentration on the quality of an IgG3:κ monoclonal antibody during production
5. High-Throughput In-Use and Stress Size Stability Screening of Protein Therapeutics Using Algorithm-Driven Dynamic Light Scattering
6. Evaluating the effect of in-process material on the binding mechanisms of surrogate viral particles to a multi-modal anion exchange resin
7. Automated 2D-HPLC method for characterization of protein aggregation with in-line fraction collection device
8. Integrating Process Scouting Devices (PSDs) With Bench-Scale Devices: Challenges and Opportunities for Mammalian Cell Culture
9. A design space exploration for control of Critical Quality Attributes of mAb
10. Simple NMR methods for evaluating higher order structures of monoclonal antibody therapeutics with quinary structure
11. Product and process understanding to relate the effect of freezing method on glycation and aggregation of lyophilized monoclonal antibody formulations
12. Bioreactor Process Parameter Screening Utilizing a Plackett-Burman Design for a Model Monoclonal Antibody
13. Characterization of Non-Infectious Virus-Like Particle Surrogates for Viral Clearance Applications
14. Exploring the linkage between cell culture process parameters and downstream processing utilizing a plackett‐burman design for a model monoclonal antibody
15. Real time monitoring of bioreactor mAb IgG3 cell culture process dynamics via Fourier transform infrared spectroscopy: Implications for enabling cell culture process analytical technology
16. Post-translational structural modifications of immunoglobulin G and their effect on biological activity
17. Virus filtration: A review of current and future practices in bioprocessing
18. Separation Methods and Orthogonal Techniques
19. Determination of the NISTmAb Primary Structure
20. Fermentanomics: Relating quality attributes of a monoclonal antibody to cell culture process variables and raw materials using multivariate data analysis
21. Viral Filtration: A Review of Current and Future Practices in Bioprocessing
22. Development of a modular virus clearance package for anion exchange chromatography operated in weak partitioning mode
23. The ELISA Detectability and Potency of Pegfilgrastim Decrease in Physiological Conditions: Key Roles for Aggregation and Individual Variability
24. Multi-Attribute Method for Quality Control of Therapeutic Proteins
25. Bioprocess: Robustness with Respect to Mycoplasma Species
26. Impacts of intentional mycoplasma contamination on CHO cell bioreactor cultures
27. Validation and optimization of viral clearance in a downstream continuous chromatography setting
28. Prediction of N-linked Glycoform Profiles of Monoclonal Antibody with Extracellular Metabolites and Two-Step Intracellular Models
29. Defining the mechanistic binding of viral particles to a multi‐modal anion exchange resin
30. Metabolic responses and pathway changes of mammalian cells under different culture conditions with media supplementations
31. Farewell and Thanks!
32. Trans‐acting oligodeoxythymidine phosphorothioate triester reagents for transient transfection optimized and facilitated by a high‐throughput microbioreactor system
33. Comparison of purification strategies for antibodies used in a broad spectrum host cell protein immunoassay
34. The step-wise framework to design a chromatography-based hydrophobicity assay for viral particles
35. Adapting viral safety assurance strategies to continuous processing of biological products
36. A step-wise approach to define binding mechanisms of surrogate viral particles to multi-modal anion exchange resin in a single solute system
37. Emerging Technology as a Key Enabler for Modernizing Pharmaceutical Manufacturing
38. Mycoplasma Clearance and Risk Analysis in a Model Bioprocess
39. Hybridoma cell-culture and glycan profile dataset at various bioreactor conditions
40. Exploring the linkage between cell culture process parameters and downstream processing utilizing a plackett-burman design for a model monoclonal antibody
41. N-Glycosylation Design and Control of Therapeutic Monoclonal Antibodies
42. Adapting viral safety assurance strategies to continuous processing of biological products
43. Effect of amino acid supplementation on titer and glycosylation distribution in hybridoma cell cultures-Systems biology-based interpretation using genome-scale metabolic flux balance model and multivariate data analysis
44. Mechanistic failure mode investigation and resolution of parvovirus retentive filters
45. Improved Stability of a Model IgG3 by DoE-Based Evaluation of Buffer Formulations
46. Trans‐acting oligodeoxythymidine phosphorothioate triester reagents for transient transfection optimized and facilitated by a high‐throughput microbioreactor system.
47. Comparison of purification strategies for antibodies used in a broad spectrum host cell protein immunoassay.
48. Therapeutic monoclonal antibodies and consistent ends: terminal heterogeneity, detection, and impact on quality
49. Dielectric spectroscopy‐based estimation of VCD in CHO cell culture
50. Post-translational structural modifications of immunoglobulin G and their effect on biological activity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.